 of 12.4% during 2023-2028.){kind=link}
According to the latest report by IMARC Group, titled, “Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global vaccine adjuvants market size reached US$ 884 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,812 Million by 2028, exhibiting a growth rate (CAGR) of 12.4% during 2023-2028.
Vaccine adjuvants refer to compounds that enhance the immunogenic response of the body to antigens, resulting in improved long-term protection against infections. The only adjuvants approved for human use are aluminum salts and MF59. At present, vaccine adjuvants are gaining immense traction across the globe as they help elevate antibody titers, minimize the required antigen dosage, stimulate a quick immune response and long-term memory, and enhance immune response among the young and geriatric population.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/vaccine-adjuvants-market/requestsample
Vaccine Adjuvants Market Trends and Drivers:
The global vaccine adjuvants market is primarily driven by the escalating incidence of allergies and infectious diseases, such as human papillomavirus (HPV), tuberculosis, cancer, and human immunodeficiency virus (HIV/AIDS). Moreover, the development of vaccines that offer long-term immunization effects due to the rising need for advanced treatment options for both existing and emerging fatal diseases is positively influencing the market growth. Additionally, several favorable initiatives by governments of numerous countries to promote immunization and ongoing research and development (R&D) for the introduction of new therapeutics have catalyzed market growth. Furthermore, key players are developing novel adjuvants, including AS01, ISCOM & ISCOMMATRIX, and AS02, which are undergoing clinical trials, thereby contributing to the market growth. Other factors, including significant development in healthcare infrastructure, improvements in adjuvants for human consumption, and the rising prevalence of infectious diseases, are also anticipated to propel the market growth.
Vaccine Adjuvants Market 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Adjuvance Tecchnologies Inc.
- Adjuvatis
- Agenus Inc.
- Brenntag SE
- Chemtrade Logistics Inc.
- CSL Limited
- Croda International Plc
- Invivogen
- Novavax Inc.
- OZ Biosciences
- Virometix AG.
The report has segmented the market based on product type, route of administration, diseases and application.
Breakup by Product Type:
- Adjuvant Emulsions
- Pathogen Components
- Particulate Adjuvants
- Combination Adjuvants
- Others
Breakup by Route of Administration:
- Oral
- Intramuscular
- Intranasal
- Subcutaneous
- Intradermal
- Others
Breakup by Diseases:
- Cancer
- Infectious Diseases
- Others
Breakup by Application:
- Research
- Commercial
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-adjuvants-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group